- Abstract Number: 0263
DAS28 (disease Activity Score) Elevations in Patients with Rheumatoid Arthritis (RA) Who Have Comorbid Fibromyalgia Are Explained by Elevated Tender Joint Counts as Much as by Elevated Patient Global Assessment
- Abstract Number: 0894
DAS28-gGT for the Prediction of Major Cardiovascular Events in Rheumatoid Arthritis: Results from the ESPOIR Cohort
- Abstract Number: 0657
DB-2304, a Novel anti-BDCA2 Monoclonal Antibody Drug Conjugate, Displayed Great Potency in Suppression of pDC Functions
- Abstract Number: 0021
DB-2306, a Novel Anti-TNFα Monoclonal Antibody Drug Conjugate, Is a Promising Novel Therapeutic Approach for Autoimmune Disease
- Abstract Number: 0565
Deciphering Complement System-dependent Cellular Pathways in Human Rheumatoid Arthritis Synovial Tissues Using Single-cell Computational Omics
- Abstract Number: 2187
Decision-Making Around Vaccination and Other Public Health Measures During the COVID-19 Pandemic: Experiences of Individuals with Rheumatoid Arthritis
- Abstract Number: 1585
Decreased Discontinuation and Switching of B/tsDMARD Therapy in RA Patients When Treatment Is Aligned with a Molecular Signature Response Classifier: An Analysis from the Study to Accelerate Information of Molecular Signatures (AIMS)
- Abstract Number: 1538
Decreased Prevalence of Autoimmune Connective Tissue Diseases in Type 1 and Type 2 Diabetes
- Abstract Number: 1748
Deep Immune Profiling of Cytotoxic T Cells (CTL) from Patients with Ankylosing Spondylitis Revealed a Subset of CTL Co-Expressing PD-1 and TIGIT That Resists Immune Exhaustion
- Abstract Number: 2214
Deep Immune Profiling Uncovers Novel Associations with Variable Clinical Phenotypes of Multisystem Inflammatory Syndrome in Children (MIS-C)
- Abstract Number: 0032
Defective Chaperone-mediated Autophagy Is a Hallmark of Joint Disease in Patients with Knee Osteoarthritis
- Abstract Number: 1180
Deficiency and Altered Phenotype of Mucosal-associated Invariant T Cells in Systemic Sclerosis
- Abstract Number: 0591
Deficiency of FUN14 Domain-Containing Protein 1-Mediated Mitophagy in Fibroblast-like Synoviocytes Causes Aggressive Behaviors Leading to Joint Destruction in Rheumatoid Arthritis
- Abstract Number: 1717
Deficiency of IL-23 Receptor in Podocytes of MRL/lpr lupus-prone Mice Abrogates the Development of Lupus Nephritis Despite IgG Deposition in the Glomeruli
- Abstract Number: 1916
Defining Early-stage Knee Osteoarthritis: A Scoping Review
- Abstract Number: 0096
Delayed Referral of Female Rheumatoid Arthritis Patients: Where Are We Now? A Study Spanning Three Decades
- Abstract Number: 0930
Delayed Response to Methotrexate Treatment in Rheumatoid Arthritis Patients Receiving Folic Acid Supplementation
- Abstract Number: 1451
Delayed Sleep Phase Syndrome Characterizes Circadian Disorder in Patients with Active SLE
- Abstract Number: 0098
Delays in Access to Specialized Care and Diagnosis in Patients with Systemic Lupus Erythematosus
- Abstract Number: 1481
Dementia in Adults with Systemic Lupus Erythematosus 65 Years of Age and Above: A National Administrative Claims Data Analysis
- Abstract Number: 2152
Depression and Other Neurological Disorders Are Associated with Biologic DMARD Failure in Psoriatic Arthritis
- Abstract Number: 1021
Depression as a Modulator of Patient Reported, but Not Physician Observed, Outcomes in Psoriatic Arthritis
- Abstract Number: 1486
Derivation and Internal Validation of a Disease-specific Cardiovascular Risk Prediction Model for Patients with Psoriatic Arthritis and Psoriasis
- Abstract Number: 1168
Dermal Fibroblast-derived Exosomes Drive Profibrotic Macrophage Activation in Systemic Sclerosis
- Abstract Number: 1695
Dermatomyositis (DM) Macrophages Upregulate Genes Involved in the Remodeling of the Extracellular Matrix and Activate Keratinocytes in a Novel 3D Tissue Model of DM Skin Disease
- Abstract Number: 1944
Description and Delays in Care in the Bridge to Adult Care from Childhood for Young Adults with Rheumatic Disease (BACC YARD) Program, a Pediatric-to-Adult Rheumatology Transition Program
- Abstract Number: 2030
Designing of a Phase 2, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Assess the Efficacy and Safety of Nipocalimab, an FcRn Inhibitor, in Adults with Primary Sjögren’s Syndrome
- Abstract Number: 1957
Detangling Heterogeneity in Contemporary Undifferentiated Arthritis – a Large Cohort Study Using Latent Class Analysis
- Abstract Number: 1970
Detecting Inflammatory Changes in Seronegative Inflammatory Arthritis with Use of Musculoskeletal Ultrasound Studies
- Abstract Number: 0508
Detecting the Critical Factors in the Pathogenesis of Anti-melanoma Differentiation-associated Gene 5–positive Dermatomyositis (MDA5 DM) by Gene Expression Analysis of Peripheral Blood
- Abstract Number: 2254
Detection of Active Inflammatory and Structural Changes Indicative of Axial Spondyloarthritis on MRI of Sacroiliac Joint Using a Deep Learning Framework
- Abstract Number: 0166
Detection of the Novel Autoantibodies Against Transcription Factor Sp4 Is Related with Low Risk of Cancer in Idiopathic Inflammatory Myopathy Patients
- Abstract Number: 1494
Determinants of Clinically Important Worsening in Early Axial Spondyloarthritis: Analysis of the DESIR Cohort over 5 Years
- Abstract Number: 0211
Determinants of COVID-19 Vaccine Hesitancy in a Predominantly Black Population with Cutaneous Lupus Erythematosus
- Abstract Number: 1945
Determinants of Patient’s Global Assessment of Disease Severity and Predictors of Disease Course in Juvenile Fibromyalgia
- Abstract Number: 1641
Determination and Characterization of Patient Subgroups with Different Pain Progression in Hand Osteoarthritis
- Abstract Number: 1887
Determining the Long-term Safety and Efficacy of JAK Inhibitors in the Treatment of Dermatomyositis: A Retrospective Cohort Study
- Abstract Number: 2134
Deucravacitinib Long-term Efficacy and Safety in Plaque Psoriasis: 2-Year Results from the Phase 3 POETYK PSO Program
- Abstract Number: 1000
Deucravacitinib Reduces Interferons, B Cell Pathways, and Serological Biomarkers of Systemic Lupus Disease Activity: Pharmacodynamic Analysis from the Phase 2 PAISLEY Study
- Abstract Number: 2136
Deucravacitinib, an Oral, Selective Tyrosine Kinase 2 Inhibitor, in a Phase 2 Trial in Psoriatic Arthritis: Achievement of Minimal Disease Activity and Its Components
- Abstract Number: 1366
Developing a Mobile App to Facilitate Disease Activity Assessment in Localized Scleroderma
- Abstract Number: 1526
Developing a Screening Tool for the Detection of Interstitial Lung Disease in Systemic Sclerosis: The ILD-RISC Risk Score
- Abstract Number: 0224
Developing and Evaluating a Rheumatology Nurse Competency Framework to Guide Professional Development and Career Progression
- Abstract Number: 0531
Development and Performance of a Diagnostic Precision Biomarker for Seronegative Rheumatoid Arthritis Based on DNA Methylation in Blood
- Abstract Number: 1291
Development and Pilot Implementation of a Predictive Model to Identify Visits Appropriate for Telehealth
- Abstract Number: 1208
Development and Validation of a Prognostic Model for Methotrexate Discontinuation with Abnormal Monitoring Blood-test Results: A Cohort Study Using Data from Clinical Practice Research Datalink Gold and Aurum
- Abstract Number: 0318
Development and Validation of Algorithms to Identify Cutaneous Lupus Patients Using Diagnostic Codes and Prescription Data
- Abstract Number: 0724
Development of a Global Strategy to Strengthen Health Systems for Prevention and Management of Musculoskeletal Health
- Abstract Number: 0664
Development of a Novel Gene Expression-based Molecular Score That Characterizes Individual Lupus Patients
- Abstract Number: 2185
Development of a Novel Regulatory T Cell-Based Therapy for Patients with Rheumatoid Arthritis
- Abstract Number: 0947
Development of a Person-Centered Family Planning Decision Aid for Women with Rheumatic Diseases
- Abstract Number: 0971
Development of a Theory-based Educational Intervention for Fatigue in Systemic Lupus Erythematosus (SLE) Using Human-centered Design Methodology
- Abstract Number: 1279
Development of ACR Longitudinal Digital Quality Measures for Systemic Lupus Erythematosus: A Literature Review and Modified Delphi Consensus Study
- Abstract Number: 1273
Development of ACR Longitudinal Digital Quality Measures for Systemic Lupus Erythematosus: Data Availability and Preliminary Measure Performance in the RISE Registry
- Abstract Number: 1915
Development of an MRI-based Definition of Knee Osteoarthritis: Data from the Multicenter Osteoarthritis Study
- Abstract Number: 0788
Development of Autoantibodies and Their Association with Flare-ups of Rheumatic Diseases in Adult Patients with Autoimmune Inflammatory Rheumatic Diseases (AIIRD) and the General Population Following BNT162b2 mRNA COVID-19 Vaccination – Results of 1-year Prospective Follow-up Study
- Abstract Number: 0512
Development of CARRA Biologic Consensus Treatment Plans for Management of Refractory Moderate Juvenile Dermatomyositis
- Abstract Number: 1380
Development of Core and Expanded Datasets to Align Registries and Advance International Collaborative Research for Childhood-onset Systemic Lupus Erythematosus
- Abstract Number: 1258
Development of International Consensus on a Standardized Image Acquisition Protocol for Diagnostic Evaluation of the Sacroiliac Joints by MRI – an ASAS-SPARTAN Collaboration
- Abstract Number: 0582
Development of Novel Glucocorticoid as Immunology Antibody-Drug Conjugate Payload for the Treatment of Autoimmune and Inflammatory Diseases
- Abstract Number: 1561
Development of Posterior Uveitis in Behçet’s Syndrome Patients with Vitreous Cells Without Any Other Posterior Involvement
- Abstract Number: 2036
Development of Systemic Sclerosis in Patients with Primary Sjogren Syndrome and Raynauds Phenomenon
- Abstract Number: 1954
Development of the Patient-Important Outcomes Data Repository (PIONEER) for Rheumatic Diseases; An Enhanced Database Combining Electronic Medical Data with Insight from Chart Reviews
- Abstract Number: 2228
Development of the Takayasu’s Arteritis Integrated Disease Activity Index
- Abstract Number: 1351
Development, Implementation, and Usability Testing of a New Rheumatoid Arthritis Patient-Reported Outcomes EHR-based Dashboard: A Mixed-Method Study
- Abstract Number: 0852
Development, Refinement and Weighting of Candidate Criteria for Axial Disease in Juvenile Spondyloarthritis: An International Collaboration
- Abstract Number: 1188
Diabetes Burden and Effects of Apremilast on Changes in Cardiometabolic Parameters in Patients with Psoriasis (PsO) or Psoriatic Arthritis (PsA) in a Real-World Setting
- Abstract Number: 1230
Diabetes Mellitus Nailfold Capillaroscopy Pattern: DM Pattern
- Abstract Number: 1760
Diagnoses Rates in Rheumatoid Arthritis, Psoriatic Arthritis and Systemic Lupus Erythematosus Patients During COVID-19
- Abstract Number: 1751
Diagnosing the Cardiovascular Risk of VIOXX: A Place for Rofecoxib in Pain Management
- Abstract Number: 0902
Diagnosis of Mental Disorder Complicated by Rheumatoid Arthritis: A Study of the Validity of a Psychiatrist’s Diagnosis and Questionnaire Method
- Abstract Number: 0176
Diagnostic Accuracy and Clinical Relevance of Muscle Biopsy in Patients with Suspected Myositis
- Abstract Number: 1613
Diagnostic Delay and Less Intensive Therapy for People with Psoriatic Arthritis Compared with Rheumatoid Arthritis: A Nested Matched Cohort Study from Within the UK National Early Inflammatory Arthritis Audit
- Abstract Number: 1507
Diagnostic Delay of More Than 6 Months Contributes to Poor Patient-Reported Outcome Measures in Psoriatic Arthritis
- Abstract Number: 2208
Diagnostic Performance of Hip Ultrasound in Calcium Pyrophosphate Deposition Disease
- Abstract Number: 1030
Diagnostic Usefulness of Anti-PPM1A-IgM in Patients with Ankylosing Spondylitis
- Abstract Number: 1467
Dickkopf Homolog 3 (DKK3) as a Prognostic Marker in Lupus Nephritis: A Prospective Monocentric Experience
- Abstract Number: 1337
Dietary Mineral Intake of an Inner-City Population and Its Impact on Disease Activity in Patients with SLE
- Abstract Number: 1353
Dietary Practices and Beliefs of Patients with Rheumatic Diseases and Relationship with Symptoms: Results of a Multicenter Cross-sectional Study
- Abstract Number: 0619
Differences Between Patients in Remission with Active Rheumatoid Arthritis by Histological and Molecular Comparisons
- Abstract Number: 0999
Differences in Chromatin Accessibility Pre- and Post-Induction Therapy in Pediatric Lupus
- Abstract Number: 1383
Differences in Clinical and Patient-reported Outcomes in Juvenile Dermatomyositis by Race and Ethnicity
- Abstract Number: 0377
Differences in Early-onset vs. Late-onset Psoriatic Arthritis: Data from the RESPONDIA and REGISPONSER Studies
- Abstract Number: 1847
Differences in Key Patient-reported Outcome Domains Identified by the Patient Acceptable Symptom State in the Adult SAPHO and Chronic Nonbacterial Osteomyelitis Observational Study (The SAPHO-CNO Study)
- Abstract Number: 0206
Differences in Medicinal Cannabis Use According to Demography, Rationale, and Patient-Physician Interactions Between the United States and Canada
- Abstract Number: 0844
Differences in Skin Advanced Glycation End-Products Levels Between Subgroups of Achilles Tendinopathy
- Abstract Number: 1415
Different Bioactive Lipid Profile Predicts Response to TNF or IL6 Inhibitors in Rheumatoid Arthritis: Result of the CorEvitas CERTAIN Comparative Effectiveness Study
- Abstract Number: 1763
Different Humoral but Similar Cellular Responses of Patients with Autoimmune Inflammatory Rheumatic Diseases Under Disease-modifying Anti-rheumatic Drugs After COVID-19 Vaccination
- Abstract Number: 0015
Differential Antigen Binding of Closely Related Monoclonal ACPA
- Abstract Number: 0068
Differential Diagnostic Coding Patterns and Associated Sociodemographic Factors in Childhood-Onset Lupus Nephritis
- Abstract Number: 0668
Differential Expression of Interferon Related Genes in SLE Patients of Asian and European Ancestries Abstract
- Abstract Number: 1158
Differential Plasma Levels of S100 Proteins in Male versus Female Patients with Ankylosing Spondylitis
- Abstract Number: 1039
Differential Retention of Adalimumab and Etanercept Biosimilars Compared to Originator Treatments: Results of a Retrospective French Multicentre Study
- Abstract Number: 1153
Differentially Expressed Genes in Males and Females with Ankylosing Spondylitis (AS): Transcriptomics of IL-17-producing Cells in Patients with AS
- Abstract Number: 1666
Differentiation of Injury-associated Macrophages in Lupus Kidneys Is Conserved in Humans and Lupus Mouse Models
- Abstract Number: 1487
Differentiation of Therapeutic Antibodies Targeting Interleukin (IL)-23
- Abstract Number: 2014
Difficult to Treat Rheumatoid Arthritis: Prevalence of Different Objective Patterns, Predictive Characteristics, and Associated Factors in 1-Year Follow-Up
- Abstract Number: 0428
Difficult to Treat Spondyloarthritis: Patients with a High Biologic Switch Rate and the Factors Influencing It; A Real World as Clinic Experience
- Abstract Number: 1364
Diffuse Juvenile Systemic Sclerosis Patients Show Distinct Organ Involvement and Have More Severe Disease in the Largest jSSc Cohort of the World. Results from the the Juvenile Scleroderma Inception Cohort
- Abstract Number: 0423
Direct and Indirect Effect of TNFi on BASMI Components in People with Axial Spondyloarthritis: A Longitudinal Study
- Abstract Number: 1617
Direct Comparison of Ultrasound, [18F]Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging: Early Diagnostics in Patients Suspected of Giant Cell Arteritis
- Abstract Number: 0401
Direct to Patient Screening of Psoriatic Arthritis: Clinical Findings and Outcomes of Patient-Driven Rheumatology Referrals
- Abstract Number: 0833
Disability Among Persons with Chronic Severe Back Pain: Results from a Nationally Representative Population Based Sample
- Abstract Number: 1070
Discordance of Patient, Physician and Nurse Practitioner Assessment of Disease Burden in Systemic Sclerosis
- Abstract Number: 0179
Discordant Monozygotic Twins with Juvenile Dermatomyositis: Genetic and Clinical Studies
- Abstract Number: 0031
Discovery of GSTT1 Gene That Promotes Osteogenic Differentiation of Adipose Stem Cells
- Abstract Number: 0488
Discrepancies in Temporal Artery Biopsy Positivity Rate Among White and Black Patients Suspected of Having Giant Cell Arteritis: Experience from a Tertiary Academic Medical Center
- Abstract Number: 2047
Discriminative Power of Salivary Gland Ultrasound in Relation to Symptom-based Endotypes in Suspected and Definite Primary Sjögren’s Syndrome
- Abstract Number: 1013
Discriminatory Capacity of the ASAS Health Index in Patients with Axial Spondyloarthritis Treated in a Tight Control Setting versus Standard of Care
- Abstract Number: 0712
Disease Prevalence and Patient Characteristics in Patients with and Without Scleroderma Renal Crisis – A National US-based Inpatient Comparison Study
- Abstract Number: 2217
Disease Response in Rheumatoid Arthritis Across 4 Biologic Therapies Associates with Improvement in Paraoxonase-1 Activity
- Abstract Number: 0117
Disparities in Prescription Medications Among Myositis Patients in a Large Urban Medical Center
- Abstract Number: 2106
Disparities of African American Mortality Trends in South Carolina Lupus Cohort
- Abstract Number: 1565
Dissection of Ocular and Peripheral Blood Immune Phenotypes Suggests Preferential Transmigration of CD16+ Monocytes to Effector Sites in Behçet’s Disease
- Abstract Number: 1556
Distinct Clinical and Therapeutic Features Between Parenchymal and Non-parenchymal Manifestations in Neurobehçet’s Disease
- Abstract Number: 1054
Distinct Differences in Complement Perturbation Between Scleroderma-related Interstitial Lung Disease with and Without Emphysema
- Abstract Number: 0625
Distinct Effects of JAK Inhibitor and TNF Inhibitors on Circulating B Cell Phenotypes in Rheumatoid Arthritis Patients
- Abstract Number: 1171
Distinct Immune Cell Subsets in Systemic Sclerosis-related Interstitial Lung Disease
- Abstract Number: 1390
Distinct Patterns of Multimorbidity Are Associated with Longitudinal Disease Activity and Functional Status in a Multicenter, Prospective Rheumatoid Arthritis Cohort
- Abstract Number: 0016
Distinct Transcriptomic and Epigenetic Profiles Mediated by Disease Activity in SLE
- Abstract Number: 1228
Distinctive Alterations in the Functional Anatomy of the Cerebral Cortex in Pain-sensitized Osteoarthritis and Fibromyalgia Patients
- Abstract Number: 2029
Distinctive Clinical Profiles Associated with anti-SSA/Ro60, anti-Ro52/TRIM21 and Anti-SSB/La Reactivity
- Abstract Number: 0687
DNA- and NET-Binding Beta-2 Glycoprotein I in a Large Cohort of Antiphospholipid Antibody-Positive Patients
- Abstract Number: 2255
Do Fatty Lesions Explain the Association Between Inflammation and New Syndesmophytes in Patients with Radiographic Axial Spondyloarthritis?
- Abstract Number: 1496
Do Patients in MDA Report Low Disease Activity Regardless of Which of the MDA Criteria Are Met?
- Abstract Number: 2002
Do SMS and Email Reminders Increase the Rate of Seasonal Influenza Vaccination in RA Patients Treated with Biologics: A Nested Randomized Controlled Trial Within the ART Registry?
- Abstract Number: 0122
Documentation of Social Determinants of Health Among Individuals with Systemic Rheumatic and Musculoskeletal Diseases
- Abstract Number: 0110
Does Access Reduce Excess Use? Lupus Outcomes in Two Distinct Socioeconomic Groups Seen by University Rheumatologists
- Abstract Number: 2045
Does Ancestry Influence Primary Sjögren’s Syndrome Phenotype or Severity?
- Abstract Number: 2077
Does Early Complete Remission Preclude Adverse Outcomes in Lupus Nephritis?
- Abstract Number: 1905
Does Exercise Before Surgery Predict Trajectories of Physical Activity After Knee Replacement?
- Abstract Number: 0087
Does Limited English Proficiency Lead to Additional Health Inequity in Medically Vulnerable Populations in Outpatient Rheumatology?
- Abstract Number: 1003
Does LLDAS Definition Match the Rheumatologist Opinion? The First Visit Evaluation of a Longinudital Spanish Multicenter Study to Assess Reasons of Disagreement
- Abstract Number: 1903
Does Pain Sensitization by Pressure Pain Thresholds and Temporal Summation Predict Persistent Pain in Persons with Hand OA?
- Abstract Number: 2102
Does Remission According Definition of Remission in SLE (DORIS) 2021 Match the Treating Rheumatologist Judgment? Analysis at Recruitment of a Prospective Study of 500 SLE Patients from a Spanish Multicenter Cohort
- Abstract Number: 1264
Does Vein Wall Thickness Have Prognostic Value in Behcet’s Disease? A Prospective Follow up Study
- Abstract Number: 2109
Domains Contributing to Minimal Disease Activity Non-Achievement in Patients with Psoriatic Arthritis Receiving Golimumab: Post Hoc Analysis of a Phase 3, Randomized, Double-blind, Placebo-controlled Study
- Abstract Number: 0312
Dose-dependent Suppression of T Cell-Dependent Antibody Response in Healthy Volunteers by KPL-404, an Anti-CD40 Monoclonal Antibody, Supports Phase 2 Study in Patients with Rheumatoid Arthritis
- Abstract Number: 1169
Downregulated Fli1 in Systemic Sclerosis Myeloid Cells Contributes to Enhanced Transendothelial Migration
- Abstract Number: 0499
Drivers of Heterogeneity in Synovial Fibroblasts in Rheumatoid Arthritis
- Abstract Number: 2013
Drug Free Remission in Rheumatoid Arthritis: Data from the Randomized Controlled ARCTIC REWIND Trial
- Abstract Number: 2099
Drug Repurposing for Treating Lupus Nephritis Based on Transcriptome Profiling and Autoimmunity-Related Serological Markers
- Abstract Number: 1616
Drug Use and Pregnancy Outcomes in Pregnant Women with Systemic Vasculitis: A Nation Wide Cohort Study
- Abstract Number: 0037
Dual (and Dueling) Fibroblast Differentiation Is Integral to the Pathogenesis of Anti-Ro Mediated Congenital Heart Block and Provides a Novel Biomarker of Severity
- Abstract Number: 1195
Duloxetine and the Risk for Acute Myocardial Infarction and Stroke in Medicare Recipients with Non-Cancer Pain
- Abstract Number: 0391
Dynamics of Nail Psoriasis with Guselkumab Treatment and Withdrawal in Association with Skin Response and Patient-reported Outcomes Based on a post Hoc Analysis of Clinical Trial Data
- Abstract Number: 0148
Dysferlin Associated Autoinflammatory Disease Causing Systemic Inflammation and Sterile Lung Abcesses Through Impaired Efferocytosis
- Abstract Number: 2264
Dysregulated Interferon Gamma Signals Promote Systemic Autoimmunity in STAT1 Gain of Function Syndrome
- Abstract Number: 1968
Dysregulation of γδ-T Cells in Individuals at Risk of Developing Rheumatoid Arthritis
ACR Convergence 2022
November 10-14, 2022. Philadelphia, PA.